Azitra is trading 0.16% up at $0.13, essentially unchanged from the August 19, 2026 close, with no new company-specific announcement, filing, earnings release, or regulatory catalyst found for August 20, 2026.

  • Latest reported results and business update came August 12, covering Q2 financial results, ATR-COSF data, and continued ATR-04 enrollment.
  • Biotech sentiment is stronger pre-market, with XBI up 2.27%, but Azitra’s flat move does not clearly confirm a sector-driven catalyst.